These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 32572480)

  • 1. Pharmacological prevention of fractures in patients undergoing glucocorticoid therapies: a systematic review and network meta-analysis.
    Deng J; Silver Z; Huang E; Zheng E; Kavanagh K; Wen A; Cheng W; Dobransky J; Sanger S; Grammatopoulos G
    Rheumatology (Oxford); 2021 Feb; 60(2):649-657. PubMed ID: 32572480
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of osteoporosis pharmacotherapies in preventing fracture among oral glucocorticoid users: a network meta-analysis.
    Amiche MA; Albaum JM; Tadrous M; Pechlivanoglou P; Lévesque LE; Adachi JD; Cadarette SM
    Osteoporos Int; 2016 Jun; 27(6):1989-98. PubMed ID: 26782683
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical effectiveness of denosumab, raloxifene, romosozumab, and teriparatide for the prevention of osteoporotic fragility fractures: A systematic review and network meta-analysis.
    Simpson EL; Martyn-St James M; Hamilton J; Wong R; Gittoes N; Selby P; Davis S
    Bone; 2020 Jan; 130():115081. PubMed ID: 31626995
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of Pharmacological Therapies for the Prevention of Fractures in Postmenopausal Women: A Network Meta-Analysis.
    Barrionuevo P; Kapoor E; Asi N; Alahdab F; Mohammed K; Benkhadra K; Almasri J; Farah W; Sarigianni M; Muthusamy K; Al Nofal A; Haydour Q; Wang Z; Murad MH
    J Clin Endocrinol Metab; 2019 May; 104(5):1623-1630. PubMed ID: 30907957
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative efficacy of bisphosphonates in short-term fracture prevention for primary osteoporosis: a systematic review with network meta-analyses.
    Zhou J; Ma X; Wang T; Zhai S
    Osteoporos Int; 2016 Nov; 27(11):3289-3300. PubMed ID: 27273112
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of medications on prevention of secondary osteoporotic vertebral compression fracture, non-vertebral fracture, and discontinuation due to adverse events: a meta-analysis of randomized controlled trials.
    Jin YZ; Lee JH; Xu B; Cho M
    BMC Musculoskelet Disord; 2019 Aug; 20(1):399. PubMed ID: 31472671
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Indirect comparison of teriparatide, denosumab, and oral bisphosphonates for the prevention of vertebral and nonvertebral fractures in postmenopausal women with osteoporosis.
    Zhang L; Pang Y; Shi Y; Xu M; Xu X; Zhang J; Ji L; Zhao D
    Menopause; 2015 Sep; 22(9):1021-5. PubMed ID: 25944523
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Results of indirect and mixed treatment comparison of fracture efficacy for osteoporosis treatments: a meta-analysis.
    Freemantle N; Cooper C; Diez-Perez A; Gitlin M; Radcliffe H; Shepherd S; Roux C
    Osteoporos Int; 2013 Jan; 24(1):209-17. PubMed ID: 22832638
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A systematic review and economic evaluation of bisphosphonates for the prevention of fragility fractures.
    Davis S; Martyn-St James M; Sanderson J; Stevens J; Goka E; Rawdin A; Sadler S; Wong R; Campbell F; Stevenson M; Strong M; Selby P; Gittoes N
    Health Technol Assess; 2016 Oct; 20(78):1-406. PubMed ID: 27801641
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical effectiveness of bisphosphonates for the prevention of fragility fractures: A systematic review and network meta-analysis.
    Sanderson J; Martyn-St James M; Stevens J; Goka E; Wong R; Campbell F; Selby P; Gittoes N; Davis S
    Bone; 2016 Aug; 89():52-58. PubMed ID: 27262775
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative efficacy of bone anabolic therapies in women with postmenopausal osteoporosis: A systematic review and network meta-analysis of randomized controlled trials.
    Hernandez AV; Pérez-López FR; Piscoya A; Pasupuleti V; Roman YM; Thota P; Herrera A
    Maturitas; 2019 Nov; 129():12-22. PubMed ID: 31547908
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Importance of Time Point-Specific Indirect Treatment Comparisons of Osteoporosis Treatments: A Systematic Literature Review and Network Meta-Analyses.
    Willems D; Javaid MK; Pinedo-Villanueva R; Libanati C; Yehoshua A; Charokopou M
    Clin Ther; 2022 Jan; 44(1):81-97. PubMed ID: 35058055
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of antifracture drugs in postmenopausal, male and glucocorticoid-induced osteoporosis--usefulness of alendronate and risedronate.
    Iwamoto J; Takeda T; Sato Y
    Expert Opin Pharmacother; 2007 Nov; 8(16):2743-56. PubMed ID: 17956196
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of calcium and vitamin D compounds on bone mineral density in patients undergoing glucocorticoid therapies: a network meta-analysis.
    Deng J; Silver Z; Huang E; Zheng E; Kavanagh K; Panicker J
    Clin Rheumatol; 2021 Feb; 40(2):725-734. PubMed ID: 32681366
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vitamin K to prevent fractures in older women: systematic review and economic evaluation.
    Stevenson M; Lloyd-Jones M; Papaioannou D
    Health Technol Assess; 2009 Sep; 13(45):iii-xi, 1-134. PubMed ID: 19818211
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antidiabetic and antiosteoporotic pharmacotherapies for prevention and treatment of type 2 diabetes-induced bone disease: protocol for two network meta-analyses.
    Deng J; Abbas U; Chang O; Dhivagaran T; Sanger S; Bozzo A
    BMJ Open; 2020 Feb; 10(1):e034741. PubMed ID: 32014879
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical review. Comparative effectiveness of drug treatments to prevent fragility fractures: a systematic review and network meta-analysis.
    Murad MH; Drake MT; Mullan RJ; Mauck KF; Stuart LM; Lane MA; Abu Elnour NO; Erwin PJ; Hazem A; Puhan MA; Li T; Montori VM
    J Clin Endocrinol Metab; 2012 Jun; 97(6):1871-80. PubMed ID: 22466336
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy and safety of 18 anti-osteoporotic drugs in the treatment of patients with osteoporosis caused by glucocorticoid: A network meta-analysis of randomized controlled trials.
    Liu Z; Zhang M; Shen Z; Ke J; Zhang D; Yin F
    PLoS One; 2020; 15(12):e0243851. PubMed ID: 33326444
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Abaloparatide for risk reduction of nonvertebral and vertebral fractures in postmenopausal women with osteoporosis: a network meta-analysis.
    Reginster J-; Bianic F; Campbell R; Martin M; Williams SA; Fitzpatrick LA
    Osteoporos Int; 2019 Jul; 30(7):1465-1473. PubMed ID: 30953114
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alfacalcidol versus plain vitamin D in the treatment of glucocorticoid/inflammation-induced osteoporosis.
    Ringe JD; Faber H; Fahramand P; Schacht E
    J Rheumatol Suppl; 2005 Sep; 76():33-40. PubMed ID: 16142849
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.